Lithium bis(trimethylsilyl)amide - solution 1.0 M in MTBE

CAS: 4039-32-1

Ref. 3D-FL165181

Informação sobre produto

• Nome: Lithium bis(trimethylsilyl)amide - solution 1.0 M in MTBE
• Sinónimos: (Hexamethyldisilazane)lithium, 1,1,1,3,3,3-Hexamethyldisilazane Lithium Salt, 1,1,1-Trimethyl-N-(trimethylsilyl)silanamine lithium salt, Bis(trimethylsilyl)amide de lithium, Bis(trimethylsilyl)amidolithium, Disilazane, 1,1,1,3,3,3-hexamethyl-, Li deriv., Disilazane, 1,1,1,3,3,3-hexamethyl-, lithium salt, Hexamethyldisilazane lithium salt, Hexamethyldisilazide, Lithium, Lhmds, LiHMDS, Lithiobis(trimethylsilyl)amide, Lithiohexamethyldisilazane, Lithium bis(trimethylsilyl)amide, Lithium bis(trimethylsilyl)amide(1-), Lithium bis(trimethylsilyl)amine, Lithium hexamethyldisilazanate, Lithium hexamethyldisilazane, Lithium hexamethyldisilazanide, Lithium hexamethyldisilazide, Lithium, [bis(trimethylsilyl)amino]-, Lithiumbis(Trimethylsilyl)Amide, Lithiumbis(trimethylsilyl)amid, Litiobis(Trimetilsilil)Amida, N,N-Bis(trimethylsilyl)amine lithium salt, N-Lithiohexamethyldisilazane, Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, lithium salt (1:1), [1,1,1-Trimethyl-N-(trimethylsilyl)silanaminato]lithium, Silanamine, 1,1,1-trimethyl-N-(trimethylsilyl)-, lithium salt, lithium 1,1,1,3,3,3-hexamethyldisilazan-2-ide

Descrição

Lithium bis(trimethylsilyl)amide is an amide that has been used to treat bowel disease, hyperproliferative disease, and infectious diseases. It has antimicrobial activity because it inhibits the growth of certain bacteria by interfering with their metabolism. Lithium bis(trimethylsilyl)amide has been shown to have a reaction mechanism similar to other amides, which may be due to its ability to inhibit the enzyme fatty acid synthase and thus interfere with the synthesis of fatty acids. This drug also has potential anticancer properties because it inhibits the growth of cancer cells in vitro and in vivo.

• Marca: Biosynth

Propriedades químicas

• Peso molecular: 167.33 g/mol
• Fórmula: C₆H₁₈LiNSi₂
• Pureza: Min. 95%